Cure Childhood Cancer Inc.

CURE is dedicated to conquering childhood cancer through funding innovative research. Through generosity of donors, CURE is able to provide more than $4 million in annual support to promising research projects.

For the current fiscal year, we are funding 12 specific projects, including our largest single grant to date – a $1.5 million award for the development of the Aflac Cancer Center Precision Medicine Program. The program envisions personalized, non-toxic and curative cancer therapy for all children.

CURE is also passionate about serving families with children undergoing cancer treatment, walking alongside them every step of their journey. Through financial assistance, transportation and lodging, survivorship programs, meals, bereavement care, and many other programs, cure walks alongside children with cancer and their families.

• Research: Drive innovative research, with a priority given to precision medicine, to improve survival of children with cancer and reduce adverse effects of treatment.
o With a minimum of 50% of CURE's annual operating budget, support strong, innovative research rated highly by CURE's Scientific Advisory Council, with priority given to projects aimed at the 20% of children currently not surviving today's methods of treatment. We seek projects that will be at the bedside in 2-3 year.
o Prioritize investment in precision medicine for childhood cancer patients.
o Continue to prioritize innovative research being done at the Aflac Cancer Center
• Patient & Family Services: Expand existing programs to serve growing patient population in Atlanta at Children's Healthcare of Atlanta, Savannah at Memorial Children's and Jacksonville at Wolfson's Hospital
o Increase total Family Emergency Fund budget by (25%?) and increase per family limits of Level 1 and Level 2 support
o Continue to expand bereavement care opportunities

CURE currently maintains a staff of twenty seasoned individuals, a highly motivated board of directors, and an advisory council that leads the organization in accomplishing its goals.

With respect to curing childhood cancer, all of our funding decisions are guided by our Scientific Advisory Council. This group of doctors, scientists, and researchers are charged with advising CURE in scientific matters pertaining to childhood cancer. They conduct a thorough review of all research proposals to assess both scientific merit and alignment with CURE’s goals. Together they offer guidance to ensure every dollar we invest in research is spent wisely and affords the best chance that one day, every child diagnosed with cancer receives a safe and effective treatment.

As it pertains to our patient and family goals, we work with social workers at the hospitals to identify and qualify needs so that we can meet them in an appropriate and timely manner.

Over the last 10 years, CURE has invested $34 million in research including solely funding the Aflac Precision Medicine Program which promises genetic research to offer individualized therapies for children. Dramatic increase in the amount of patient and family support available and used by families in crisis. Over the past decade, CURE has provided more than $2 million in emergency financial support and served more than 125,000 meals in the hospital.